GNW Stock Cash Flow Statements

Genworth Financial Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Genworth Financial Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-09-30	2023-06-30	2023-03-31	2022-06-30	2022-03-31	2021-09-30	2021-06-30	2021-03-31	2020-06-30	2020-03-31	2019-03-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2014-12-31	2014-03-31	2013-06-30	2013-03-31	2012-09-30	2011-12-31	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31	2008-12-31	2008-09-30	2008-06-30	2008-03-31	2007-12-31	2007-09-30	2007-06-30	2007-03-31	2006-12-31	2006-09-30	2006-06-30	2006-03-31

cash flows from (used by) operating activities:
net income	83,000,000	85,000,000	30,000,000	118,000,000	110,000,000	169,000,000	60,000,000	228,000,000	94,000,000	219,000,000	179,000,000	318,000,000	240,000,000	195,000,000	71,999,510	-72,000,000	230,000,000	210,000,000	249,000,000	165,000,000	265,000,000	175,000,000	271,000,000	216,000,000	220,000,000	108,000,000	-240,000,000	-238,000,000	-708,000,000	219,000,000	180,000,000	141,000,000	70,000,000	140,000,000	116,000,000	-126,000,000	122,000,000	77,000,000	212,000,000	75,000,000	45,000,000	-50,000,000	-469,000,000	-321,000,000	-258,000,000	-109,000,000	116,000,000	178,000,000	339,000,000	379,000,000	324,000,000	373,000,000
less income from discontinued operations, net of taxes	7,000,000	5,000,000				1,000,000															0																											0	0
adjustments to reconcile net income to net cash from (used by) operating activities:
amortization of fixed maturity securities discounts and premiums	-37,000,000	-32,000,000	-28,000,000	-27,000,000	-41,000,000	-23,000,000	-26,000,000	-33,000,000	-25,000,000	-50,000,000	-34,000,000	-58,000,000	-48,000,000	-32,000,000	34,999,950	-35,000,000	-16,000,000	-30,000,000
net investment (gains) losses	28,000,000	-27,000,000	41,000,000	-66,000,000	61,000,000	-49,000,000	43,000,000	-39,000,000	11,000,000	-8,000,000	-28,000,000		-70,000,000	-33,000,000	-152,000,007	152,000,000	-74,000,000	-13,000,000	14,000,000	31,000,000				-34,000,000
changes in fair value of market risk benefits and associated hedges	-10,000,000	18,000,000	-3,000,000	21,000,000	-8,000,000	-23,000,000	-24,000,000	-19,000,000	17,000,000
charges assessed to policyholders	-138,000,000	-138,000,000	-135,000,000	-144,000,000	-146,000,000	-139,000,000	-139,000,000	-147,000,000	-144,000,000	-142,000,000	-150,000,000	-155,000,000	-158,000,000	-159,000,000	157,999,686	-158,000,000	-165,000,000	-169,000,000	-181,000,000	-178,000,000	-179,000,000	-169,000,000	-182,000,000	-183,000,000	-193,000,000	-191,000,000	-202,000,000	-193,000,000	-197,000,000	-187,000,000	-202,000,000	-202,000,000	-202,000,000	-183,000,000	-159,000,000	-139,000,000	-134,000,000	-120,000,000	-113,000,000	-110,000,000	-121,000,000	-108,000,000	-103,000,000	-105,000,000	-108,000,000	-96,000,000	-100,000,000	-106,000,000	-96,000,000	-98,000,000	-97,000,000	-83,000,000	-78,000,000	-91,000,000	-86,000,000
amortization of deferred acquisition costs and intangibles	57,000,000	60,000,000	62,000,000	62,000,000	60,000,000	65,000,000	65,000,000	64,000,000	72,000,000	84,000,000	92,000,000	106,000,000	86,000,000	77,000,000	-115,999,791	116,000,000	91,000,000	83,000,000	112,000,000	104,000,000	119,000,000	83,000,000	139,000,000	94,000,000	112,000,000	99,000,000	207,000,000	563,000,000	156,000,000	134,000,000	137,000,000	122,000,000	162,000,000	171,000,000	185,000,000	166,000,000	227,000,000	179,000,000	184,000,000	180,000,000	143,000,000	212,000,000	247,000,000	264,000,000	208,000,000	209,000,000	203,000,000	209,000,000	202,000,000	207,000,000	213,000,000	176,000,000	170,000,000	208,000,000	173,000,000
deferred income taxes	-22,000,000	2,000,000	-46,000,000	-7,000,000	-49,000,000	-1,000,000	28,000,000	70,000,000	37,000,000	71,000,000	57,000,000	70,000,000	73,000,000	59,000,000	11,000,028	-11,000,000	75,000,000	32,000,000	57,000,000	26,000,000	-602,000,000	68,000,000	73,000,000	93,000,000	-3,000,000	7,000,000	-79,000,000	-220,000,000	-293,000,000	17,000,000	-31,000,000	-182,000,000	-32,000,000	-151,000,000	-37,000,000	-183,000,000	62,000,000	-72,000,000	-101,000,000	158,000,000	-43,000,000	-89,000,000	-502,000,000	-177,000,000	-307,000,000	29,000,000	25,000,000	35,000,000	64,000,000	80,000,000	73,000,000	149,000,000	37,000,000	59,000,000	123,000,000
derivative instruments, limited partnerships and other	-133,000,000	-27,000,000	-118,000,000	-80,000,000	-125,000,000	-138,000,000	-156,000,000	-138,000,000	-84,000,000	-58,000,000	-105,000,000	-63,000,000	-76,000,000	-113,000,000	-346,999,809	347,000,000
long-term incentive compensation expense	14,000,000	11,000,000	14,000,000	12,000,000	11,000,000	14,000,000
change in certain assets and liabilities:
accrued investment income and other assets	-3,000,000	-47,000,000	-24,000,000	10,000,000	-30,000,000	-68,000,000	-58,000,000	7,000,000	-73,000,000	-27,000,000	-43,000,000	-48,000,000	-11,000,000	-58,000,000	106,999,869	-107,000,000	-258,000,000	-42,000,000	-44,000,000	-45,000,000	51,000,000	2,000,000	56,000,000	-79,000,000	-27,000,000	-159,000,000	27,000,000	-82,000,000	43,000,000	-109,000,000	63,000,000	-42,000,000	-165,000,000	12,000,000	-117,000,000	-2,000,000	-55,000,000	67,000,000	-43,000,000	45,000,000	-165,000,000	100,000,000	-70,000,000	-136,000,000	507,000,000	-80,000,000	-239,000,000	38,000,000	-203,000,000	35,000,000	-34,000,000	-17,000,000	-154,000,000	111,000,000	33,000,000
insurance reserves	187,000,000	149,000,000	287,000,000	217,000,000	133,000,000	140,000,000	378,000,000	252,000,000	273,000,000	245,000,000	249,000,000	171,000,000	181,000,000	326,000,000	-327,999,326	328,000,000	301,000,000	348,000,000	314,000,000	377,000,000	423,000,000	396,000,000	429,000,000	377,000,000	296,000,000	36,000,000	577,000,000	404,000,000	1,443,000,000	550,000,000	642,000,000	541,000,000	671,000,000	550,000,000	557,000,000	639,000,000	559,000,000	632,000,000	576,000,000	610,000,000	633,000,000	1,052,000,000	468,000,000	1,263,000,000	-378,000,000	940,000,000	1,209,000,000	972,000,000	840,000,000	774,000,000	775,000,000	753,000,000	951,000,000	737,000,000	739,000,000
current tax liabilities	-54,000,000	34,000,000	-94,000,000	11,000,000	30,000,000	67,000,000			2,000,000			-4,000,000	0	-4,000,000	4,999,999	-5,000,000	8,000,000	-11,000,000	2,000,000	-39,000,000	23,000,000	5,000,000	5,000,000	-37,000,000	64,000,000	-8,000,000	56,000,000	20,000,000	7,000,000	-182,000,000	58,000,000	202,000,000	6,000,000	123,000,000	25,000,000	140,000,000	-102,000,000	-48,000,000	-163,000,000	-174,000,000	-142,000,000	114,000,000	83,000,000	13,000,000	24,000,000	-150,000,000	-25,000,000	-22,000,000	-17,000,000	96,000,000	84,000,000	-53,000,000	64,000,000	-97,000,000	141,000,000
other liabilities, policy and contract claims and other policy-related balances	48,000,000	-59,000,000	36,000,000	31,000,000	0	-122,000,000	-1,000,000	10,000,000	-175,000,000	84,000,000	-289,000,000	116,000,000	259,000,000	-319,000,000	-117,999,345	118,000,000	-18,000,000	186,000,000	22,000,000	-144,000,000	628,000,000	-102,000,000	-46,000,000	-112,000,000	-305,000,000	406,000,000	-59,000,000	449,000,000
cash from (used by) operating activities—discontinued operations
net cash from (used by) operating activities	6,000,000	34,000,000			7,000,000	-107,000,000			17,000,000					-247,000,000
cash flows from (used by) investing activities:
proceeds from maturities and repayments of investments:
fixed maturity securities	621,000,000	639,000,000	654,000,000	550,000,000	671,000,000	649,000,000	532,000,000	531,000,000	613,000,000	765,000,000	730,000,000	1,033,000,000	1,189,000,000	1,031,000,000	-920,998,313	921,000,000	902,000,000	988,000,000	1,045,000,000	934,000,000	1,370,000,000	1,038,000,000	1,298,000,000	1,060,000,000	840,000,000	840,000,000	1,152,000,000	994,000,000	1,589,000,000	1,135,000,000	1,608,000,000	1,212,000,000	1,253,000,000	1,158,000,000	1,627,000,000	1,287,000,000	1,245,000,000	1,116,000,000	941,000,000	948,000,000	1,265,000,000	991,000,000	901,000,000	1,298,000,000	1,171,000,000	1,344,000,000	974,000,000
commercial mortgage loans	111,000,000	202,000,000	155,000,000	164,000,000	140,000,000	127,000,000	117,000,000	115,000,000	154,000,000	199,000,000	115,000,000	209,000,000	263,000,000	129,000,000	-138,999,698	139,000,000	127,000,000	193,000,000	145,000,000	205,000,000	125,000,000	147,000,000	141,000,000	166,000,000	172,000,000	192,000,000	242,000,000	204,000,000	237,000,000	139,000,000	262,000,000	212,000,000	168,000,000	279,000,000	148,000,000	276,000,000	230,000,000	127,000,000	136,000,000	191,000,000	138,000,000	142,000,000	239,000,000	211,000,000	156,000,000	236,000,000	254,000,000	246,000,000	354,000,000	295,000,000	261,000,000	302,000,000
limited partnerships and other invested assets	52,000,000	50,000,000	86,000,000	50,000,000	49,000,000	59,000,000	35,000,000	36,000,000	31,000,000	48,000,000	51,000,000
proceeds from sales of investments:
fixed maturity and equity securities	708,000,000	334,000,000	501,000,000	421,000,000	1,083,000,000	635,000,000	244,000,000	848,000,000	441,000,000	721,000,000	581,000,000	285,000,000	529,000,000	777,000,000	-368,998,343	369,000,000	1,714,000,000	1,405,000,000	1,128,000,000	792,000,000	957,000,000	682,000,000	414,000,000	2,173,000,000	1,867,000,000	905,000,000	3,058,000,000	512,000,000	745,000,000	708,000,000	935,000,000	1,310,000,000	1,418,000,000	2,838,000,000	1,009,000,000	1,314,000,000	936,000,000	1,372,000,000	1,021,000,000	2,465,000,000	1,680,000,000	716,000,000	947,000,000	1,642,000,000	1,272,000,000	1,104,000,000	922,000,000
purchases and originations of investments:
short-term investments			-2,000,000	11,000,000	-2,000,000	17,000,000	-8,000,000	-8,000,000	1,000,000	26,000,000	-50,000,000	52,000,000	-104,000,000	28,000,000	-47,999,941	48,000,000
policy loans	51,000,000	1,000,000	4,000,000	22,000,000			34,000,000	22,000,000	10,000,000	0	14,000,000	12,000,000	25,000,000	3,000,000	-8,999,990	9,000,000	12,000,000	20,000,000	13,000,000	2,000,000	20,000,000	7,000,000			-100,000,000	10,000,000	2,000,000	20,000,000	1,000,000				62,000,000	6,000,000	-9,000,000	9,000,000	-13,000,000	-59,000,000	-5,000,000	5,000,000	679,000,000	-245,000,000	-8,000,000	-12,000,000	-16,000,000	-152,000,000	-3,000,000	-1,000,000	-15,000,000	-141,000,000	-5,000,000	4,000,000	-12,000,000	-123,000,000	-12,000,000
other	-8,000,000	-7,000,000	-11,000,000	-10,000,000	-18,000,000	-17,000,000	-18,000,000	-22,000,000	2,000,000	-120,000,000	15,000,000	2,000,000	-27,000,000	92,000,000	-99,999,951	100,000,000	48,000,000		-24,000,000	22,000,000	-24,000,000	-1,000,000	-20,000,000	-9,000,000	-4,000,000	13,000,000	-73,000,000	-34,000,000	-19,000,000	-12,000,000	15,000,000	-32,000,000	-14,000,000
net cash from (used by) investing activities	174,000,000	-14,000,000										-72,000,000	206,000,000	335,000,000		-551,000,000	277,000,000
cash flows from (used by) financing activities:
deposits to universal life and investment contracts	129,000,000	129,000,000	127,000,000	135,000,000	139,000,000	133,000,000	134,000,000	155,000,000	148,000,000	155,000,000	159,000,000	162,000,000	173,000,000	176,000,000	-179,999,484	180,000,000	198,000,000	302,000,000	248,000,000	255,000,000	-45,000,000	473,000,000	211,000,000	218,000,000	239,000,000	571,000,000	564,000,000	551,000,000	792,000,000	814,000,000	475,000,000	445,000,000	897,000,000	648,000,000	560,000,000	905,000,000	658,000,000	684,000,000	490,000,000	470,000,000	530,000,000
withdrawals from universal life and investment contracts	-341,000,000	-221,000,000	-251,000,000	-286,000,000	-360,000,000	-317,000,000	-415,000,000	-402,000,000	-491,000,000	-361,000,000	-418,000,000	-439,000,000	-565,000,000	-578,000,000	492,999,086	-493,000,000	-581,000,000	-629,000,000	-586,000,000	-591,000,000	-394,000,000	-912,000,000	-624,000,000	-467,000,000	-504,000,000	-517,000,000	-467,000,000	-598,000,000	-638,000,000	-505,000,000	-1,381,000,000	-678,000,000	-551,000,000	-654,000,000	-1,115,000,000	-1,479,000,000	-1,216,000,000	-821,000,000	-913,000,000	-1,306,000,000	-2,438,000,000
proceeds from issuance of long-term debt			0	0														0	0	441,000,000							0
debt issuance costs			0	0
repayment and repurchase of long-term debt			-31,000,000	-17,000,000	-770,000,000	-6,000,000	0	0	-11,000,000	-48,000,000	-82,000,000	-519,000,000	-14,000,000	-470,000,000	419,999,529	-420,000,000		-1,000,000							-36,000,000	-326,000,000	0		0				0	0
repurchase of subsidiary shares	-16,000,000	-12,000,000	-13,000,000	-14,000,000	-9,000,000	-9,000,000	-1,000,000	-8,000,000	-4,000,000								-12,000,000	-40,000,000	-13,000,000	-36,000,000	-2,000,000						-51,000,000	0						0		0
treasury stock acquired in connection with share repurchases	-32,000,000	-45,000,000	-54,000,000	-36,000,000	-36,000,000	-63,000,000	-80,000,000	-113,000,000	-68,000,000
dividends paid to noncontrolling interests	-6,000,000	-5,000,000	-6,000,000	-5,000,000	-5,000,000	-5,000,000	-5,000,000	-5,000,000	-4,000,000						8,999,991	-9,000,000	-28,000,000	-33,000,000	-14,000,000	-36,000,000	-15,000,000	-40,000,000	-13,000,000	-39,000,000	-12,000,000	-52,000,000	-12,000,000	-79,000,000	-29,000,000	-13,000,000	-13,000,000	-13,000,000	-12,000,000	-32,000,000	-12,000,000	-11,000,000	-11,000,000	-11,000,000	-10,000,000
net cash from (used by) financing activities																	-375,000,000			47,000,000
net change in cash, cash equivalents and restricted cash	-94,000,000	-157,000,000	-9,000,000	125,000,000	-20,000,000	-263,000,000	-180,000,000	421,000,000	-47,000,000	433,000,000	-280,000,000	-277,000,000	250,000,000	-692,000,000	857,999,256	-858,000,000	44,000,000	262,000,000	-600,000,000	-32,000,000
cash, cash equivalents and restricted cash at beginning of period	0	2,048,000,000	0	0	0	2,215,000,000	0	0	1,799,000,000	0	1,571,000,000	0	0	2,656,000,000	-3,340,996,659	3,341,000,000	2,177,000,000	0	0	2,875,000,000
cash, cash equivalents and restricted cash at end of period	-94,000,000	1,891,000,000	-9,000,000	125,000,000	-20,000,000	1,952,000,000	-180,000,000	421,000,000	1,752,000,000	433,000,000	1,291,000,000	-277,000,000	250,000,000	1,964,000,000	-2,482,997,403	2,483,000,000	2,221,000,000	262,000,000	-600,000,000	2,843,000,000
net cash used by financing activities		-177,000,000	-255,000,000	-276,000,000	-285,000,000	-299,000,000	-352,000,000	-390,000,000	-428,000,000	-393,000,000	-326,000,000	-265,000,000	-433,000,000	-780,000,000	956,998,856	-957,000,000		-407,000,000			-498,000,000	-515,000,000	-451,000,000	-304,000,000
adjustments to reconcile net income to net cash from operating activities:
cash used by operating activities—discontinued operations							0	-1,000,000	-1,000,000			-296,000,000	-18,000,000	-174,000,000
net cash from operating activities			27,000,000				175,000,000					61,000,000			-679,998,701	680,000,000	134,000,000	412,000,000	452,000,000	109,000,000	622,000,000	624,000,000	653,000,000	655,000,000	810,000,000	256,000,000	433,000,000	647,000,000	1,298,000,000	61,000,000	586,000,000	60,000,000	207,000,000	1,093,000,000	336,000,000	360,000,000	419,000,000	427,000,000	130,000,000	77,000,000	485,000,000	586,000,000	783,000,000	2,250,000,000	1,073,000,000	995,000,000	1,125,000,000	1,023,000,000	1,226,000,000	1,478,000,000	1,064,000,000	1,015,000,000	1,353,000,000	1,226,000,000	771,000,000
net cash from investing activities			220,000,000	240,000,000	258,000,000	143,000,000	-4,000,000	553,000,000	364,000,000	397,000,000	138,000,000														-1,029,000,000	-255,000,000	1,759,000,000	-902,000,000	167,000,000	-204,000,000	265,000,000	453,000,000	-424,000,000	-145,000,000	496,000,000	-127,000,000	-965,000,000	451,000,000	-1,174,000,000	-1,566,000,000	1,751,000,000	-619,000,000	1,254,000,000	1,794,000,000	-673,000,000	444,000,000	400,000,000	-78,000,000	34,000,000	-1,149,000,000	-687,000,000	-1,344,000,000	-802,000,000	-103,000,000	-649,000,000
effect of exchange rate changes on cash, cash equivalents and restricted cash															29,999,988	-30,000,000	8,000,000	-10,000,000	-31,000,000	-21,000,000
less (income) income from discontinued operations, net of taxes				3,000,000						1,000,000	2,000,000	-12,000,000	5,000,000	-21,000,000												19,000,000	73,000,000	21,000,000			-6,000,000	20,000,000
acquisition costs deferred							-2,000,000	-2,000,000	-2,000,000	1,000,000	-2,000,000	-3,000,000	-1,000,000	-2,000,000	3,999,991	-4,000,000	-17,000,000	-23,000,000	-22,000,000	-18,000,000	-21,000,000	-23,000,000	-22,000,000	-22,000,000	-41,000,000	-50,000,000	-67,000,000	-71,000,000	-117,000,000	-119,000,000	-107,000,000	-105,000,000	-147,000,000	-213,000,000	-229,000,000	-229,000,000	-218,000,000	-199,000,000	-193,000,000	-167,000,000	-172,000,000	-174,000,000	-194,000,000	-246,000,000	-276,000,000	-338,000,000	-331,000,000	-354,000,000	-315,000,000	-430,000,000	-309,000,000	-357,000,000	-302,000,000	-318,000,000	-289,000,000
stock-based compensation expense							12,000,000	10,000,000	15,000,000	10,000,000	10,000,000	7,000,000	14,000,000	11,000,000	-10,999,981	11,000,000	7,000,000	9,000,000	9,000,000	7,000,000	13,000,000	11,000,000	8,000,000	10,000,000	9,000,000	7,000,000	2,000,000	6,000,000	9,000,000	8,000,000	8,000,000	9,000,000	7,000,000	8,000,000	7,000,000	13,000,000	8,000,000	12,000,000	11,000,000	9,000,000	2,000,000	7,000,000	8,000,000	5,000,000	3,000,000	6,000,000	9,000,000
less cash, cash equivalents and restricted cash of discontinued operations at end of period
cash, cash equivalents and restricted cash of continuing operations at end of period							-180,000,000	421,000,000	1,752,000,000	433,000,000	1,291,000,000	-277,000,000	250,000,000	1,964,000,000	-2,482,997,403	2,483,000,000
proceeds from sale of business, net of cash transferred												0	0	270,000,000
cash used by investing activities—discontinued operations												0
redemption of non-recourse funding obligations															314,999,685	-315,000,000									0	-1,620,000,000		-15,000,000		-8,000,000					-6,000,000	0	0	0	-6,000,000	0	0	0	-12,000,000					0
proceeds from sale of subsidiary shares to noncontrolling interests																											0	0
cash used by financing activities—discontinued operations
adjustments to reconcile net income to net cash used by operating activities:
cash used by operating activities — discontinued operations											-30,000,000
net cash used by operating activities											-92,000,000
cash used by investing activities — discontinued operations
cash flows from operating activities:
net investment gains																						-85,000,000
other invested assets												69,000,000	63,000,000	44,000,000	-33,999,929	34,000,000	17,000,000	271,000,000	-11,000,000	104,000,000	-180,000,000	117,000,000	38,000,000	-676,000,000	-101,000,000	34,000,000	214,000,000	0	-127,000,000	111,000,000	139,000,000	-26,000,000	153,000,000	-471,000,000	-59,000,000	96,000,000	-8,000,000	1,147,000,000	344,000,000	-436,000,000	470,000,000			-922,000,000	-307,000,000	80,000,000	-77,000,000	431,000,000	-740,000,000	-99,000,000	-159,000,000	-41,000,000	-41,000,000	-1,000,000	-9,000,000
cash flows used by financing activities:
cash from financing activities—discontinued operations																												6,000,000																				0	0	-11,000,000	-10,000,000
cash from (used by) investing activities—discontinued operations														-67,000,000
goodwill impairment																													299,000,000
derivative instruments and limited partnerships																	-30,000,000
redemption and repurchase of non-recourse funding obligations																															-8,000,000	-4,000,000	-234,000,000	-18,000,000
repayment of borrowings related to securitization entities																		-8,000,000	-4,000,000	-8,000,000	-18,000,000	-4,000,000	-5,000,000	-7,000,000	-20,000,000	-10,000,000	-10,000,000	-7,000,000	-8,000,000	-7,000,000	-15,000,000	-17,000,000	-24,000,000	-19,000,000	-12,000,000	-15,000,000	-15,000,000	-20,000,000	-11,000,000
cash from operating activities—discontinued operations																												22,000,000			2,000,000	1,000,000																0	0	-2,000,000	27,000,000
cash flows used by investing activities:
net cash used by investing activities																			-31,000,000	-167,000,000	-81,000,000	-155,000,000	-381,000,000	-142,000,000
restricted commercial mortgage loans related to a securitization entity																	3,000,000
repayment of borrowings related to a securitization entity
trading securities, limited partnerships and derivative instruments																		-168,000,000
restricted commercial mortgage loans related to securitization entities																		4,000,000	8,000,000	8,000,000	4,000,000	7,000,000	5,000,000	6,000,000	14,000,000	6,000,000	14,000,000	6,000,000	8,000,000	7,000,000	14,000,000	17,000,000	23,000,000	19,000,000	22,000,000	12,000,000	13,000,000	15,000,000	12,000,000
payments for business purchased, net of cash acquired																						0																															-157,000,000
amortization of fixed maturity securities discounts and premiums and limited partnerships																				-25,000,000	-40,000,000	-31,000,000	-43,000,000	-33,000,000	-29,000,000	-38,000,000		-31,000,000		-28,000,000
trading securities, held-for-sale investments and derivative instruments																				-152,000,000	-13,000,000	285,000,000	66,000,000	365,000,000
(gain) loss on sale of businesses
cash from operating activities—held for sale
proceeds from sale of businesses, net of cash transferred
payments for businesses purchased, net of cash acquired																																	0	0	-4,000,000									-2,000,000	-3,000,000	-12,000,000	-5,000,000
cash used by investing activities—held for sale
return of capital to noncontrolling interests
cash from financing activities—held for sale
effect of exchange rate changes on cash and cash equivalents (includes —, — and (35) related to businesses held for sale
net change in cash and cash equivalents																					39,000,000	-17,000,000	-165,000,000	234,000,000	-627,000,000	-1,909,000,000	2,185,000,000	-446,000,000	1,441,000,000	146,000,000	-182,000,000	166,000,000	-133,000,000	840,000,000	610,000,000	-466,000,000	-988,000,000	1,120,000,000	-1,536,000,000	-2,142,000,000	1,770,000,000	-1,690,000,000	-264,000,000	2,226,000,000	-759,000,000	2,093,000,000	677,000,000	-55,000,000	190,000,000	699,000,000	-212,000,000	167,000,000	-49,000,000	442,000,000	34,000,000
cash and cash equivalents at beginning of period																					0	0	0	2,784,000,000	0	5,993,000,000	0	0	0	4,214,000,000	0	3,653,000,000	0	0	3,132,000,000		0	0	5,002,000,000		0	0	7,328,000,000		0	0	3,091,000,000		0	0	2,469,000,000		0	0	1,875,000,000
cash and cash equivalents at end of period																					39,000,000	-17,000,000	-165,000,000	3,018,000,000	-627,000,000	4,084,000,000	2,185,000,000	-446,000,000	1,441,000,000	4,360,000,000	-182,000,000	3,819,000,000	-133,000,000	840,000,000	3,742,000,000		-988,000,000	1,120,000,000	3,466,000,000		1,770,000,000	-1,690,000,000	7,064,000,000		-759,000,000	2,093,000,000	3,768,000,000		190,000,000	699,000,000	2,257,000,000		-49,000,000	442,000,000	1,909,000,000
less cash and cash equivalents held for sale at end of period																										41,000,000
cash and cash equivalents of continuing operations at end of period																								3,018,000,000	-586,000,000	4,043,000,000	2,299,000,000	-434,000,000	1,441,000,000	4,360,000,000	-184,000,000	3,797,000,000															3,768,000,000		190,000,000	706,000,000	2,250,000,000
gain on sale of business
effect of exchange rate changes on cash and cash equivalents																						29,000,000	14,000,000	25,000,000	-1,000,000	31,000,000			-80,000,000	20,000,000	-70,000,000	-48,000,000	22,000,000	26,000,000	-1,000,000	48,000,000	80,000,000	-2,000,000	-5,000,000	-3,000,000	152,000,000	181,000,000	-98,000,000	1,000,000	-176,000,000	-32,000,000	-51,000,000	34,000,000	-46,000,000	22,000,000	-4,000,000	-20,000,000	-9,000,000	3,000,000	-12,000,000
net increase in trading securities, held-for-sale investments and derivative instruments																									722,000,000	21,000,000	8,000,000	-54,000,000	96,000,000	26,000,000	62,000,000	-27,000,000	-27,000,000	656,000,000	35,000,000	-213,000,000	-6,000,000	61,000,000	58,000,000	-55,000,000
cash flows from investing activities:
cash from investing activities—held for sale
cash flows from financing activities:
net cash from financing activities																									-407,000,000	-1,941,000,000	-23,000,000	-146,000,000	56,000,000	269,000,000	-963,000,000	-299,000,000	62,000,000	-134,000,000	-221,000,000	-747,000,000	-522,000,000	244,000,000	-487,000,000	-650,000,000	-618,000,000	-1,838,000,000	-2,203,000,000	-1,819,000,000	-983,000,000	686,000,000	-797,000,000	-1,034,000,000	-1,024,000,000	348,000,000	-585,000,000	516,000,000	-591,000,000	-684,000,000	-76,000,000
effect of exchange rate changes on cash and cash equivalents (includes —, (35) and (39) related to businesses held for sale
gain on sale of businesses
net investment losses																									-30,000,000	19,000,000		51,000,000		17,000,000	-21,000,000	61,000,000	-9,000,000	-5,000,000	28,000,000	39,000,000	-105,000,000	139,000,000	70,000,000	96,000,000	122,000,000	53,000,000	770,000,000		816,000,000	518,000,000	226,000,000		48,000,000	51,000,000	19,000,000
gain on sale of subsidiary																										-20,000,000							0							0
loss on sale of subsidiary
amortization of fixed maturity discounts and premiums and limited partnerships																															-35,000,000	-5,000,000	-10,000,000	-6,000,000
proceeds from sale of a subsidiary, net of cash transferred																																	0
effect of exchange rate changes on cash and cash equivalents (includes (35), (39) and —related to businesses held for sale
cash from investing activities—discontinued operations																												-35,000,000																				0	0	144,000,000	-41,000,000
less cash and cash equivalents of discontinued operations at end of period																												-12,000,000			2,000,000	22,000,000																			7,000,000
effect of exchange rate changes on cash and cash equivalents (includes and 2 related to discontinued operations
proceeds from the issuance of long-term debt																																	0	0	397,000,000										0				0
proceeds from the sale of subsidiary shares to noncontrolling interests																																								-1,000,000
other liabilities and other policy-related balances																														-285,000,000	-164,000,000	-474,000,000	-206,000,000	-18,000,000	-57,000,000	299,000,000	77,000,000	-282,000,000	-392,000,000	-571,000,000	310,000,000	-727,000,000	519,000,000	-62,000,000	820,000,000	58,000,000	28,000,000	-119,000,000	517,000,000	468,000,000	-1,000,000	178,000,000	349,000,000	245,000,000	-421,000,000
net cash transferred related to the sale of a subsidiary																																								39,000,000
short-term borrowings and other																																		-59,000,000	-33,000,000	-691,000,000	199,000,000	-248,000,000	-37,000,000	-12,000,000	-33,000,000	-248,000,000	-82,000,000	901,000,000	90,000,000	1,000,000	-19,000,000	-127,000,000	141,000,000	-132,000,000	69,000,000	-93,000,000
proceeds from issuance of common stock																																								0								0	0
amortization of fixed maturity discounts and premiums																																			-18,000,000	-44,000,000	-16,000,000	-19,000,000	24,000,000	-19,000,000	-3,000,000	24,000,000	82,000,000	34,000,000			-8,000,000	3,000,000	-28,000,000	-7,000,000	3,000,000	0	6,000,000	6,000,000	6,000,000
dividends paid to stockholders																																												-45,000,000	-42,000,000	-44,000,000	-44,000,000	-44,000,000	-40,000,000	-39,000,000	-40,000,000	-42,000,000	-34,000,000	-34,000,000	-35,000,000
stock-based compensation awards exercised																																												0	0	3,000,000	2,000,000	10,000,000	-1,000,000	16,000,000	14,000,000	17,000,000	12,000,000
acquisition of treasury stock																																												0	0	0	-76,000,000	-24,000,000	-102,000,000	-765,000,000	-233,000,000	-325,000,000	-122,000,000	-74,000,000	-479,000,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
repayment and repurchase of long-term borrowings																																									-70,000,000	-660,000,000	-79,000,000
proceeds from the issuance of long-term borrowings																																					0
less gain on sale from discontinued operations, net of taxes																																																2,000,000
cash received from sale of discontinued operations, net of cash sold																																																0	0
proceeds from issuance of non-recourse funding obligations																																																0	0			315,000,000	300,000,000	0	750,000,000
net increase in trading, held-for-sale investments and derivative instruments
net increase in trading and derivative instruments																																											-56,000,000
proceeds from issuance of investment contracts																																											773,000,000	1,297,000,000	2,297,000,000	2,463,000,000	1,547,000,000	2,158,000,000	1,637,000,000	2,330,000,000	1,877,000,000	2,161,000,000	1,811,000,000	1,718,000,000	2,056,000,000
redemption and benefit payments on investment contracts																																											-2,803,000,000	-3,653,000,000	-3,328,000,000	-2,334,000,000	-2,207,000,000	-3,007,000,000	-2,559,000,000	-2,290,000,000	-2,262,000,000	-2,115,000,000	-2,569,000,000	-2,230,000,000	-2,597,000,000
cumulative effect of accounting changes, net of taxes
proceeds from issuance of long-term borrowings
capital contribution received from our former parent
less cash and cash equivalents of discontinued operations at end of year
cash and cash equivalents of continuing operations at end of year
less gain on sale of discontinued operations, net of taxes
purchases of trading securities and held-for-sale investments, net of proceeds from sales																																													-2,000,000	0	12,000,000	-68,000,000
repayment of long-term debt																																																	0
repayment of long-term borrowings
cumulative effect of accounting change
fixed maturities																																																	1,560,000,000	1,625,000,000	1,320,000,000	2,037,000,000	1,372,000,000	1,464,000,000	1,338,000,000
fixed maturities and equity securities																																																	1,724,000,000	1,565,000,000	1,749,000,000	3,603,000,000	765,000,000	1,582,000,000	1,336,000,000
less gain from discontinued operations, net of taxes
purchases of trading securities, net of proceeds from sales																																																		-17,000,000	-3,000,000
capital contribution received from ge																																																				0	1,000,000
less net income from discontinued operations																																																			-10,000,000
adjustments to reconcile net income to net cash provided from operating activities:
corporate overhead allocation
net (gain) income from sale of discontinued operations
proceeds from sale of discontinued operations, net of cash disposal
proceeds from long-term borrowings
repayment of contingent note
cash transferred in connection with our corporate formation
cumulative effect of accounting policy change																																																					0	0	-4,000,000
net earnings																																																						317,000,000	334,000,000
adjustments to reconcile net earnings to net cash from operating activities:
mortgage loans																																																						305,000,000	249,000,000
short-term borrowing activity
net realized investment losses																																																							22,000,000
net commercial paper borrowings																																																							229,000,000
net realized investment (gains) losses
net (earnings) from discontinued operations
operating cash flows from discontinued operations
mortgage and policy loans
proceeds from sales and securitizations of investments:
investing cash flows from discontinued operations
short-term investment activity
financing cash flows from discontinued operations
short-term borrowings activity
cash transferred in connection with our corporate reorganization

We provide you with 20 years of cash flow statements for Genworth Financial stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Genworth Financial stock. Explore the full financial landscape of Genworth Financial stock with our expertly curated income statements.

The information provided in this report about Genworth Financial stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.